This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from Monday 27th June. Learn more on the Digital Experience page.

Christian Pellevoisin PhD, ERT
Scientific Director at MatTek Life Science


He is a toxicologist and scientific director at Mattek. During his career he has been involved in numerous projects that have led to the introduction of new reconstructed human tissue models and in vitro methods for evaluating the safety and efficacy of products in different industries, including cosmetics, medical devices or drugs.

As chairman of the French AFNOR commission for biocompatibility of medical devices and convenor of working group 8 of the ISO technical committee 194 , he participated and conducted projects that led to the publication of ISO standards 10993-23 for irritation and 10993-10 for skin sensitization.

Strongly committed to the recognition of alternative methods to animal experimentation, he is involved in several university courses and organizes practical training to the implementation of validated methods based on the use of reconstructed human tissues.

Agenda Sessions

  • Chairperson’s Welcome Remarks

  • Case Study: Approaches Towards In Vitro Sensitisation Testing

  • Panel: The Future of In-Vitro Testing